Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-16-065820

Options or other derivatives

  • Chief Operating Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BRENNAN DANIEL Chief Operating Officer 2016-11-01 Grant or award · Stock Option (right To Purchase) +150,000 $10.09 $1,513,500 150,000 D: show line 1 in the form
Loading xslF345X03/form4.xml…